Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Safety and Pharmacodynamics of Two Doses of Dabigatran Etexilate in Patients Undergoing Cardiac Catheterization
Brief Summary: To assess whether two doses of dabigatran etexilate (110 mg twice daily (b.i.d) and 150 mg twice daily (b.i.d)) as compared to unfractionated heparin (UFH), both in addition to a standard dual antiplatelet regimen, provide sufficient anticoagulation in the setting of elective percutaneous coronary intervention (PCI).


Options:
A: Arm Label: Short triple; Type: EXPERIMENTAL; Interventions: Drug: aspirin, Drug: clopidogrel, Drug: oral anticoagulation | Arm Label: Long triple; Type: ACTIVE_COMPARATOR; Interventions: Drug: aspirin, Drug: clopidogrel, Drug: oral anticoagulation | Intervention Type: DRUG; Name: aspirin; Assigned to Arm(s): Long triple, Short triple | Intervention Type: DRUG; Name: clopidogrel; Assigned to Arm(s): Long triple, Short triple | Intervention Type: DRUG; Name: oral anticoagulation; Assigned to Arm(s): Long triple, Short triple
B: Arm Label: Stratum 1/ASA; Type: ACTIVE_COMPARATOR; Interventions: Drug: Acetylsalicylic acid, Drug: Clopidogrel | Arm Label: Stratum 1/Rivaroxaban; Type: EXPERIMENTAL; Interventions: Drug: Rivaroxaban, Drug: Clopidogrel | Arm Label: Stratum 2/ASA; Type: ACTIVE_COMPARATOR; Interventions: Drug: Acetylsalicylic acid, Drug: Ticagrelor | Arm Label: Stratum 2/Rivaroxaban; Type: EXPERIMENTAL; Interventions: Drug: Rivaroxaban, Drug: Ticagrelor | Intervention Type: DRUG; Name: Acetylsalicylic acid; Assigned to Arm(s): Stratum 1/ASA, Stratum 2/ASA | Intervention Type: DRUG; Name: Rivaroxaban; Assigned to Arm(s): Stratum 1/Rivaroxaban, Stratum 2/Rivaroxaban | Intervention Type: DRUG; Name: Clopidogrel; Assigned to Arm(s): Stratum 1/ASA, Stratum 1/Rivaroxaban | Intervention Type: DRUG; Name: Ticagrelor; Assigned to Arm(s): Stratum 2/ASA, Stratum 2/Rivaroxaban
C: Arm Label: Edoxaban Regimen; Type: EXPERIMENTAL; Interventions: Drug: Edoxaban, Drug: Clopidogrel, Drug: Prasugrel, Drug: Ticagrelor | Arm Label: Vitamin K Antagonist Regimen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Clopidogrel, Drug: Prasugrel, Drug: Ticagrelor, Drug: Vitamin K antagonist | Intervention Type: DRUG; Name: Edoxaban; Assigned to Arm(s): Edoxaban Regimen | Intervention Type: DRUG; Name: Clopidogrel; Assigned to Arm(s): Edoxaban Regimen, Vitamin K Antagonist Regimen | Intervention Type: DRUG; Name: Prasugrel; Assigned to Arm(s): Edoxaban Regimen, Vitamin K Antagonist Regimen | Intervention Type: DRUG; Name: Ticagrelor; Assigned to Arm(s): Edoxaban Regimen, Vitamin K Antagonist Regimen | Intervention Type: DRUG; Name: Vitamin K antagonist; Assigned to Arm(s): Vitamin K Antagonist Regimen
D: Arm Label: Dabigatran 110 mg; Type: EXPERIMENTAL; Interventions: Drug: dabigatran 110 mg | Arm Label: Dabigatran 150 mg; Type: EXPERIMENTAL; Interventions: Drug: dabigatran 150 mg | Arm Label: Unfractionated Heparin; Type: ACTIVE_COMPARATOR; Interventions: Drug: unfractionated heparin | Intervention Type: DRUG; Name: dabigatran 110 mg; Assigned to Arm(s): Dabigatran 110 mg | Intervention Type: DRUG; Name: dabigatran 150 mg; Assigned to Arm(s): Dabigatran 150 mg | Intervention Type: DRUG; Name: unfractionated heparin; Assigned to Arm(s): Unfractionated Heparin

Answer: D